Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong

Gut

Volumn 38, Issue 5, 1996, Pages 675-678

  Ching, C K ^a,c   Leung, K P ^b   Yung, R W H ^b   Lam, S K ^a   Wong, B C Y ^a   Lai, K C ^a   Lai, C L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^c Manning House   (Hong Kong)

Author keywords

Chinese; Helicobacter pylori; metronidazole susceptibility

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HONG KONG; HUMAN; MALE; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; STOMACH BIOPSY;

EID: 0029938341     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.5.675     Document Type: Article

References (23)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89 (suppl): S116-28.
2. Hosking SW, Ling TKW, Chung SCS, Yung MY, Cheng AF, Sung JJ, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
3. Thijs JC, Zwet AA, van Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1994; 28: 934-8.
4. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized controlled study. Ann Intern Med 1992; 116: 705-8.
5. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994; 35: 19-22.
6. Sung JJY, Chung SCS, Ling TKW, Yung MY, Leung VKS, Ng EKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
7. NIH Consensus. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
8. Rautelin H, Seppala K, Renkonen O, Vainio U, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163-6.
9. Bell GD, Powell K, Burridge A, Pallecaros A, Jones PH, Gant PW, et al. Experience with triple anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427-35.
10. Logan RPH, Gummett PA, Misiewicz J, Karim QN, Walker MM, Baron JH. One week eradication regimen for Helicobacter pylori. Lancet 1991; 338: 1249-52.
11. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
12. Thijs JC, Zwet AA, van Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993; 28: 934-8.
13. Glupczynski Y, Burette A, Goossens H, DePrez C, Butzler JP. Results of a multicentre European Survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11: 777-81.
14. Glupeznski Y, Burrette A, DeKoster H, Nust JF, Deltenre M, Cadranel S, et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976-7.
15. Al-Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol 1994; 89: 1203-5.
16. Ching CK, Buxton C, Holgate C, Holmes GKT. Cytological brushing urea broth test a highly sensitive and specific test for Helicobacter pylori infection. Gastrointest Endosc 1991; 37: 550-1.
17. Hui WM, Lam SK, Chau PY, Ho J, Lau WY, Poon KP, et al. Pathogenetic role of Campylobacter in gastric ulcer. J Gastroenterol Hepatol 1987; 2: 309-16.
18. DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett LJ, Guerrant RL. Metronidaxole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol 1993; 31: 1971-4.
19. Lam SK, Hu WHC, Ching CK. Sucralfate in Helicobacter pylori eradication strategics. Scand J Gastroenterol (in press).
20. Logan RPH, Gummett PA, Misiewicz JJ, Karim QN, Walker MM, Baron JH. Two-week eradication regimen for metronidazole-rcsistant Helicobacter pylori. Aliment Pharmacol Ther 1993; 7: 149-53.
21. Glupczynski Y, Buordeaux L, Verhas M. Short-term double or triple oral drug treatment of Helicobacter pylori (Hp) in Central Africa. Gastroenterology 1990; 98: A48.
22. Bell GD, Powell KU, Burridge SM, Spencer G, Bolton G, Purser K, et al. Short report: Omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther 1992; 6: 751-8.
23. Thijs JC, Zwet AA, van Moolenaar W, Oom JAJ, DeKores H, Runhaar A. Clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection. Aliment Pharmacol Ther 1994; 8: 131-4.